News Headlines Article

CMS posts new view of drug spending amid mounting tension on costs
Modern Healthcare

More Medicare beneficiaries were prescribed AstraZeneca’s cholesterol drug Crestor than any other prescription medication last year, but the government spent 20% more on Sovaldi, Gilead’s new blockbuster hepatitis C drug.

That’s according to a new Web page the CMS posted intended to shed light on prescription drug use and spending. The analysis comes amid rising pressure from the public, lawmakers and presidential candidates for more scrutiny of rising drug prices.